Verified ComparisonLast updated: 29 March 2026
Tesofensine vs Liraglutide
Tesofensine activates CNS monoamine systems; Liraglutide is an approved GLP-1 agonist. Both studied in weight-loss research.
Tesofensine
Metabolic
3.8/ 5
B+
Liraglutide
Metabolic
4.2/ 5
A−
Editor's note
Liraglutide is approved; Tesofensine showed higher weight loss but development halted.
| Criterion | Tesofensine | Liraglutide |
|---|---|---|
| Mechanism | CNS monoamine reuptake | GLP-1 receptor agonism |
| Weight loss magnitude | Very high (trials) | Substantial (approved) |
| Regulatory approval | Development halted | Approved |
| Safety clarity | Concerns emerged | Established |
| Clinical adoption | None | Widespread |
Frequently asked questions
Approval, established safety, and clinical experience outweigh tesofensine's higher weight-loss potential.
Want to read the full reviews?